Melanoma in situ of other parts of the face is a localized skin cancer that arises from melanocytes, the pigment-producing cells in the skin. It is characterized by the presence of atypical melanocytes confined to the epidermis, without invasion into the dermis. Accurate coding with ICD-10 Code D03.39 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and that healthcare providers are reimbursed for their services.
ICD-10 Code D03.39 specifically denotes melanoma in situ located in other parts of the face, excluding the eyelids, ears, and lips. This code is utilized when documenting cases of melanoma that are confined to the epidermis and have not invaded deeper tissues. It is crucial for accurate clinical documentation and billing, ensuring that healthcare providers can effectively communicate the nature of the condition and receive appropriate reimbursement.
Melanoma in situ of other parts of the face is a non-invasive form of skin cancer that requires prompt medical attention to prevent progression to invasive melanoma. The condition is primarily caused by UV radiation exposure, genetic predisposition, and other environmental factors. Early detection and treatment are critical for favorable outcomes.
ICD-10 Code D03.39 is integral to SOAP notes, facilitating the documentation of patient symptoms, clinical assessments, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring that the diagnosis is accurately captured and communicated among healthcare providers.
In SOAP notes, ICD-10 Code D03.39 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of melanoma in situ. This code plays a vital role in ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Timely intervention for melanoma in situ is crucial to prevent progression. Treatment typically involves surgical excision, and in some cases, topical therapies may be considered.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D03.39 is essential for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 11600 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter excised 0.5 cm or less. |
| 11601 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter excised 0.6 to 1.0 cm. |
| 99213 | Established patient office visit, Level 3. |
Common Questions About Using ICD-10 Code D03.39 for Melanoma in situ of other parts of face
What are the risk factors for melanoma in situ?
Risk factors include excessive sun exposure, a history of sunburns, having many moles, and a family history of skin cancer. Individuals with fair skin are also at higher risk.
How is melanoma in situ treated?
Treatment typically involves surgical excision of the lesion with clear margins. In some cases, topical therapies may be considered, depending on the lesion's characteristics.
Is melanoma in situ contagious?
No, melanoma in situ is not contagious. It is a type of skin cancer that arises from genetic mutations and environmental factors, not from person-to-person transmission.
How often should patients with melanoma in situ be monitored?
Patients should have regular follow-up appointments, typically every 3 to 6 months, to monitor for any new lesions or changes in existing moles.
Clinical Notes
SOAP notes
DAP notes
AI medical notes